Bioethics, Doctors, FDA and Governance - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioethics

Doctors

FDA

Governance

Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel

Bill of Health

APRIL 26, 2022

To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. I’m concerned about that,” she said.

Bioethics

Bioethics Federal Policy Doctors Governance

Thank Ketamine for the Telehealth Extension

Bill of Health

MARCH 7, 2024

grants doctors broad discretion to prescribe medications off-label — so if a clinician believes ketamine will alleviate a patient’s depression or anxiety, they can prescribe it relatively easily. Note: FDA approval for at least one indication is necessary for other “off-label” uses of the drug. However, the U.S.

FDA

FDA Telemedicine Public Health Doctors

Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel

Thank Ketamine for the Telehealth Extension

Stay Connected